20061606|t|Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis.
20061606|a|Apolipoprotein E (APOE) promoter polymorphisms have long been linked to Alzheimer disease (AD) susceptibility, although the established data remains controversial. Using meta-analysis, our study aimed to clarify the nature of the genetic risks contributed by the three polymorphisms for developing AD. Medline, Embase, and Alzgene search identified 40 studies with 9,662 cases and 9.696 controls. Both -491A/T polymorphism (AA vs AT + TT: OR = 1.49, 95% CI=1.29-1.72) and -219T/G polymorphism (TT vs TG + GG: OR=1.30, 95% CI=1.10-1.55) showed a significant association with AD susceptibility; however, significant association was not identified in the analysis for -427T/C polymorphism (TT vs TC + CC: OR =1.03, 95% CI= 0.82-1.30). Among the APOE epsilon 4} carriers, the -491A homozygotes were at higher risk to develop AD compared with the -491T carriers (OR=1.42, 95% CI =1.15-1.76). For subjects carrying the -491AA genotype, the presence of the APOE epsilon4 allele increased the risk of AD 4.37-fold (95% CI=3.43-5.56). Subgroup analysis restricted to the late-onset or the Caucasian individuals revealed a similar association as that identified without restriction regarding -491A/T polymorphism. Our results confirm a significant but modest association between APOE promoter -491A/T and -219T/G polymorphisms and AD susceptibility.
20061606	0	16	Apolipoprotein E	Gene	348
20061606	52	71	Alzheimer's disease	Disease	MESH:D000544
20061606	102	118	Apolipoprotein E	Gene	348
20061606	120	124	APOE	Gene	348
20061606	174	191	Alzheimer disease	Disease	MESH:D000544
20061606	193	195	AD	Disease	MESH:D000544
20061606	400	402	AD	Disease	MESH:D000544
20061606	504	511	-491A/T	DNAMutation	tmVar:c|SUB|A|-491|T;HGVS:c.-491A>T;VariantGroup:2;CorrespondingGene:348;RS#:449647;CorrespondingSpecies:9606;CA#:14662613
20061606	574	581	-219T/G	DNAMutation	tmVar:c|SUB|T|-219|G;HGVS:c.-219T>G;VariantGroup:1;CorrespondingGene:348;RS#:405509;CorrespondingSpecies:9606;CA#:14703614
20061606	676	678	AD	Disease	MESH:D000544
20061606	767	774	-427T/C	DNAMutation	tmVar:c|SUB|T|-427|C;HGVS:c.-427T>C;VariantGroup:0;CorrespondingGene:348;RS#:769446;CorrespondingSpecies:9606;CA#:14662614
20061606	874	879	-491A	DNAMutation	tmVar:c|Allele|A|-491;VariantGroup:2;CorrespondingGene:348;RS#:449647;CorrespondingSpecies:9606
20061606	923	925	AD	Disease	MESH:D000544
20061606	944	949	-491T	DNAMutation	tmVar:c|Allele|T|-491;VariantGroup:2;CorrespondingGene:348;RS#:449647;CorrespondingSpecies:9606
20061606	1015	1021	-491AA	DNAMutation	tmVar:c|Allele|AA|-491;VariantGroup:2;CorrespondingGene:348;RS#:449647;CorrespondingSpecies:9606
20061606	1052	1056	APOE	Gene	348
20061606	1095	1097	AD	Disease	MESH:D000544
20061606	1284	1291	-491A/T	DNAMutation	tmVar:c|SUB|A|-491|T;HGVS:c.-491A>T;VariantGroup:2;CorrespondingGene:348;RS#:449647;CorrespondingSpecies:9606;CA#:14662613
20061606	1371	1375	APOE	Gene	348
20061606	1385	1392	-491A/T	DNAMutation	tmVar:c|SUB|A|-491|T;HGVS:c.-491A>T;VariantGroup:2;CorrespondingGene:348;RS#:449647;CorrespondingSpecies:9606;CA#:14662613
20061606	1397	1404	-219T/G	DNAMutation	tmVar:c|SUB|T|-219|G;HGVS:c.-219T>G;VariantGroup:1;CorrespondingGene:348;RS#:405509;CorrespondingSpecies:9606;CA#:14703614
20061606	1423	1425	AD	Disease	MESH:D000544
20061606	Positive_Correlation	RS#:405509;HGVS:c.-219T>G;CorrespondingGene:348	MESH:D000544
20061606	Positive_Correlation	RS#:449647;CorrespondingGene:348	MESH:D000544
20061606	Positive_Correlation	RS#:449647;HGVS:c.-491A>T;CorrespondingGene:348	MESH:D000544
20061606	Association	MESH:D000544	348
20061606	Association	MESH:D000544	348

